The optimal site for enzyme release from an enteric coated preparation is in the pyloric antrum or the proximal duodenum. A "positionedrelease" capsule (Duocap, Biorex Laboratories Ltd, London) designed to release its contents there, was developed for another drug.4 The original idea for the use of Duocaps to administer pancreatic enzymres was suggested by Professor J Kohn (Department of Biochemistry, University of Surrey). An uncontrolled study of five patients showed a significant decrease of steatorrhoea when treated with pancreatic enzymes in Duocaps compared with the preparation normally taken. The present study was designed to measure the effectiveness of delivering enzymes in Duocaps in a controlled trial.
Patients, methods, and results
In a double-blind crossover study outpatients receiving their normal diets took pancreatin BPC 320 mg three times daily before main meals, either in a Duocap or in a gelatine capsule of identical appearance for two weeks, followed by the other formulation for a further two weeks. Allocation was randomised in groups of four. Total daily intake was lipase 19 050 BP units, protease 1330 BP units, and amylase 22 860 BP units. Other supplements were stopped and no antacids or H2-receptor antagonists were given. To synchronise enzyme release with meals Duocaps were given half an hour before, and standard capsules at the start of, the meal. Patients completed a diary noting time of taking the capsules, frequency and nature of bowel actions, symptoms, and their diet.
In the last three days of both two-week periods patients collected their stools for measurement of faecal fat. Throughout both weeks during which three-day collections were made the patients were asked to keep to exactly the same diet. Stools were weighed and stored at -20°C before analysis in batches in one laboratory using Anderson's modification of the Van de Kamer5 method.
Thirteen patients, including 10 men (mean age 50-8 years, range 16-68 years) with steatorrhoea due to confirmed pancreatic insufficiency, were studied. Mean pre-study faecal fats were 102±15 mmol/24 h. Five had alcoholic pancreatitis, five idiopathic chronic pancreatitis, and three had had surgery or trauma. All were clinically stable. Eight ate low fat diets, one a diabetic diet, and the remainder ate freely.
Faecal fat output while the patients were taking the two formulations is shown in the figure. The 
Comment
Mean daily faecal fat output was decreased by 43 mmol (22%) when pancreatic replacement enzymes were taken in Duocaps compared with standard capsules. The small daily dose of lipase ( < 20 000 BP units) was chosen so that any benefit could be clearly demonstrated. Most patients had been on much higher doses previously. It is interesting that the significant reduction in steatorrhoea caused only a small and insignificant decrease in faecal wet weight and stool frequency which may reflect the low dosage used. The use of positioned-release capsules (whatever their mode of action may be) to deliver enzyme supplements resulted, however, in a significant reduction in steatorrhoea.
Unusual presentation of anorectal carcinoma
Ischiorectal abscesses are common and require hospital admission for incision and drainage under general anaesthesia. Their association with an underlying carcinoma in the rectum or anal canal has not been previously reported and we describe two cases which illustrate this association.
Case reports
Case 1-A 58-year-old woman was admitted to hospital with a two-day history of pain in the perianal region that was becoming progressively more severe. Examination revealed a hot tender swelling of the left ischiorectal fossa. She had a fever (38 7°C) and her white cell count was 13-8x 109/1. Under general anaesthesia a deeply sited ischiorectal abscess cavity was deroofed. Digital examination of the anal canal showed an indurated posterior wall from which a biopsy sample was taken. Histological examination showed a moderately differentiated squamous-cell carcinoma.
Case 2-A 63-year-old man was admitted to hospital with a right ischiorectal abscess. He had noted a change in bowel habit in the previous few months. He had no fever and had a white cell count of 13 3X 109/1. The abscess was deroofed, and rectal examination under the anaesthetic revealed an ulcerating lesion at 6 cm on the right lateral wall. Biopsy confirmed that this was an adenocarcinoma.
Comment
Carcinoma of the colon may present as an abdominal wall abscess, due to the direct spread of the colonic neoplasm to the anterior abdominal wall.' Posterior perforation may occur and present as a retroperitoneal abscess.2 A left perinephric abscess has been described as the presenting feature in cases of carcinoma of the descending colon.3 Squamous-cell carcinoma of the anal canal presenting as a groin abscess which complicated metastatic lymph nodes has been described in two cases.4 Carcinoma complicating an anal fistula is well recognised, though most anorectal abscesses are not associated with anal fistula5 and fistulas were not found in our patients.
Our experience emphasises the need to perform a thorough local examination at the time of incision of an anorectal abscess with biopsy of any suspicious lesions. Necropsy disclosed radiation-induced pneumonitis and widespread hypoxic changes throughout the cerebral cortex. Acute tubular necrosis was seen in the kidneys. No organisms were cultured from the lungs or the site of the old fracture around the pin and plate.
Tetanus is an uncommon medical emergency that has a good prognosis for full recovery provided that it is diagnosed.3 The patient reported on here would have received full immunisation against Clostridium tetani during his active service, and we postulate that the immunosuppression used for bone-marrow transplantation eradicated this immunity. No spores or bacilli of Cl tetani were found at the old fracture site, but it is possible that dormant spores may reside in the body for long periods. We suggest that spores were incorporated into the wound site before surgery and that oxygenation to the tissues around the plate became compromised after transplantation, permitting
